Taking on Pfizer.
The week's news at a glance.
Abuja, Nigeria
Nigeria filed charges against U.S. drug maker Pfizer Inc. this week, accusing it of dosing Nigerian kids with an unapproved drug during a meningitis epidemic. Pfizer says its use of the antibiotic Trovan on children in Kano state in 1996 was part of a clinical trial approved by the Nigerian government. But Kano authorities say that several children died from the drug. Kano state brought a suit against Pfizer two years ago that is still ongoing. Now the federal government has brought its own legal action, seeking nearly $7 billion in damages. The government contends that the Trovan scandal has made Nigerians reluctant to get vaccinations.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Mickey 17: 'charming space oddity' that's a 'sparky one-off'
The Week Recommends 'Remarkable' Robert Pattinson stars in Bong Joon-ho's sci-fi comedy
By Irenie Forshaw, The Week UK Published
-
EastEnders at 40: are soaps still relevant?
Talking Point Albert Square's residents are celebrating, but falling viewer figures have fans worried the soap bubble has burst
By Elizabeth Carr-Ellis, The Week UK Published
-
What will the thaw in Russia-US relations cost Europe?
Today's Big Question US determination to strike a deal with Russia over Ukraine means Europe faces 'betrayal by a long-term ally'
By Richard Windsor, The Week UK Published